A positive tuberculin skin test (TST) result in a patient with no symptoms of tuberculosis (TB) should be interpreted as an indication of latent TB infection rather than active disease. The threshold for a positive TST is an induration of 5 mm or larger, regardless of BCG vaccination history. Following a positive TST, the patient should be assessed for active TB through clinical evaluation and appropriate investigations. If active TB is excluded, consider further testing with an interferon-gamma release assay (IGRA) to confirm latent TB infection, especially if treatment decisions require additional evidence. If both TST and IGRA are positive and active TB is ruled out, offer treatment for latent TB infection to reduce the risk of progression to active disease. This approach applies to adults aged 18 to 65 who are close contacts of infectious TB cases, new entrants from high-incidence countries, healthcare workers, and immunocompromised individuals, with specific considerations for each group. Always ensure that active TB is excluded before initiating treatment for latent TB infection to prevent missing active disease that requires full treatment.
How should I interpret a positive tuberculin skin test (TST) result in a
Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP.
Posted: 14 August 2025Updated: 14 August 2025 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MSt MRCGPClinical Lead • iatroX
Related Topics
Related Questions
- Initial mx of atopic eczema in kids: skincare and topical treatments
- Atrial fibrillation in adults: when should I start anticoagulation and how do I
- What criteria should I use to refer a patient with severe allergic rhinitis to an allergist?
- How should I approach the management of a patient with allergic rhinitis who also has asthma?
- How should I approach the management of acne vulgaris in a patient with significant scarring?